Intervention to Reduce Early (Peanut) Allergy in Children (NCT04604431) | Clinical Trial Compass
CompletedNot Applicable
Intervention to Reduce Early (Peanut) Allergy in Children
United States30 participantsStarted 2020-11-04
Plain-language summary
iREACH is a five-year NIH funded study aimed at assessing and improving pediatric clinician adherence to the 2017 NIAID Prevention of Peanut Allergy (PPA) Guidelines.
iREACH has been developed as an electronic health record (EHR) integrated Clinical Decision Support (CDS) tool together with educational modules on the PPA guidelines to assist clinicians in implementing the 2017 NIAID PPA Guidelines.
A practice-based, two-arm, cluster-randomized clinical trial will evaluate the effectiveness of iREACH in increasing pediatric clinician adherence to the PPA Guidelines and explore the end-goal of reducing peanut allergy incidence by age 2.5 years in the intervention vs control group.
This study has the potential to: 1) provide evidence regarding the effectiveness of iREACH in promoting clinical processes and outcomes related to the PPA Guidelines, 2) provide important insight about practice-based implementation of PPA Guidelines by pediatric clinicians, allergists and caregivers, and 3) facilitate rapid, widespread implementation of PPA Guidelines and reduce peanut allergy incidence across the US.
Who can participate
Age range4 Months
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Practice sites
* The practice utilizes a centrally-integrated EHR.
* The practice has signed a legally-binding engagement agreement with Lurie Children's Pediatric Practice Research Group.
* The practice employs at least one physician who has completed a residency in general pediatrics and is practicing as a general pediatrician.
Pediatric Clinicians:
* Clinician is a physician, physician assistant, resident, advanced practice nurse, family practitioner, or pediatric nurse practitioner working in a pediatric practice.
* Clinician is employed by a practice that is a member of one of the participating practices in the study.
* Clinician provides well child care to infants ages 4 or 6 months.
Infants • Infant has been seen by a pediatric clinician in the intervention or control arm for a 4- and/or 6-month WCC.
Caregivers
* Is the caregiver of an infant seen for a 4- and/or 6-month WCC by a pediatric clinician in a practice belonging to the study's intervention or control arms.
* Is 18+ years of age or has parent or guardian permission to participate.
* Is able to understand the study and provide informed consent for the 12- and 24-month (child's age) survey.
Exclusion Criteria:
Practice Sites
* Sees \<50 newborn patients/year.
* Has only temporary pediatricians on staff.
* The practice pediatric clinicians do not use an EHR system.
Pediatric clinicians
* The clinician is a temporary employee.
* The clinician begins employment at participating prac…
What they're measuring
1
Pediatric Clinician Adherence to Guidelines
Timeframe: 18 months
Trial details
NCT IDNCT04604431
SponsorAnn & Robert H Lurie Children's Hospital of Chicago